title: Mitigating the emergence and spread of multidrug- and extensively drug-resistant gonorrhea: is there sufficient support in resource-poor settings in Africa?
authors.affiliation: From the *WHO Collaborating Centre for Gonorrhoea and other STIs, National Reference Laboratory for Pathogenic Neisseria, Department of Laboratory Medicine, Microbiology, Örebro University Hospital, Örebro, Sweden; and †Focal Point for the Gonococcal Antimicrobial Susceptibility Network in Latin America and the Caribbean, Department of Microbiology and Immunology, College of Medicine, Vaccine and Infectious Disease Organization-International Vaccine Centre, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
authors.forename: Magnus
authors.initials: M
authors.lastname: Unemo
authors.forename: Jo-Anne R
authors.initials: JA
authors.lastname: Dillon
mesh_terms: D000349:Africa; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D020682:Cefixime / Q000627:therapeutic use*; D024901:Drug Resistance, Multiple, Bacterial / Q000187:drug effects*; D005260:Female; D006069:Gonorrhea / Q000188:drug therapy*; D019983:Guideline Adherence; D006801:Humans; D008297:Male; D009344:Neisseria gonorrhoeae / Q000187:drug effects* / Q000302:isolation & purification; D011159:Population Surveillance; D015995:Prevalence; D011634:Public Health; D014944:World Health Organization
chemical_list: D000900:Anti-Bacterial Agents; D020682:Cefixime